TMEM50A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.945400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.897200E-01
Normal-vs-Stage2
6.598800E-01
Normal-vs-Stage3
7.951800E-01
Normal-vs-Stage4
4.828400E-01
Stage1-vs-Stage2
1.576840E-01
Stage1-vs-Stage3
8.718400E-01
Stage1-vs-Stage4
2.454600E-01
Stage2-vs-Stage3
3.602400E-01
Stage2-vs-Stage4
5.425400E-01
Stage3-vs-Stage4
3.540600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.298400E-01
Normal-vs-AfricanAmerican
6.902600E-01
Normal-vs-Asian
8.048200E-01
Caucasian-vs-AfricanAmerican
7.373000E-01
Caucasian-vs-Asian
7.917000E-01
AfricanAmerican-vs-Asian
9.311800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.033200E-01
Normal-vs-Female
6.811000E-01
Male-vs-Female
2.073200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.119200E-01
Normal-vs-Age(41-60Yrs)
4.341200E-01
Normal-vs-Age(61-80Yrs)
9.192400E-01
Normal-vs-Age(81-100Yrs)
6.714200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.456610E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.500800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.306400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.839900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.385800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.388200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.972600E-01
Normal-vs-Daily Drinker
7.306400E-01
Normal-vs-Weekly Drinker
8.742000E-01
Normal-vs-Occasional Drinker
3.653400E-01
Normal-vs-Social Drinker
9.476000E-01
Non Drinker-vs-Daily Drinker
1.895620E-01
Non Drinker-vs-Weekly Drinker
8.512000E-01
Non Drinker-vs-Occasional Drinker
1.271650E-02
Non Drinker-vs-Social Drinker
5.282600E-01
Daily Drinker-vs-Weekly Drinker
3.696400E-01
Daily Drinker-vs-Occasional Drinker
3.281000E-01
Daily Drinker-vs-Social Drinker
4.819000E-01
Weekly Drinker-vs-Occasional Drinker
5.659600E-02
Weekly Drinker-vs-Social Drinker
6.924000E-01
Occasional Drinker-vs-Social Drinker
8.245800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.759800E-01
Normal-vs-Grade 2
6.142400E-01
Normal-vs-Grade 3
6.738400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.383500E-03
Grade 1-vs-Grade 3
4.639800E-02
Grade 1-vs-Grade 4
5.759800E-01
Grade 2-vs-Grade 3
1.994640E-01
Grade 2-vs-Grade 4
6.142400E-01
Grade 3-vs-Grade 4
6.738400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.132600E-01
Normal-vs-NonDiabetic
7.858000E-01
Diabetic-vs-NonDiabetic
6.351200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.440800E-01
Normal-vs-NoPancreatitis
8.214000E-01
Pancreatitis-vs-NoPancreatitis
4.050800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.746600E-01
Normal-vs-N1
6.729800E-01
N0-vs-N1
1.101850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.843200E-01
Normal-vs-TP53-NonMutant
4.838600E-01
TP53-Mutant-vs-TP53-NonMutant
6.36319996694112E-09
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
